Lyell Immunopharma Statistics
Total Valuation
LYEL has a market cap or net worth of $320.06 million. The enterprise value is $78.32 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LYEL has 19.21 million shares outstanding. The number of shares has increased by 11.19% in one year.
| Current Share Class | 19.21M |
| Shares Outstanding | 19.21M |
| Shares Change (YoY) | +11.19% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 2.60% |
| Owned by Institutions (%) | 32.33% |
| Float | 12.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,334.31 |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,305.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.65, with a Debt / Equity ratio of 0.18.
| Current Ratio | 7.65 |
| Quick Ratio | 7.50 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.59% and return on invested capital (ROIC) is -26.91%.
| Return on Equity (ROE) | -76.59% |
| Return on Assets (ROA) | -25.39% |
| Return on Invested Capital (ROIC) | -26.91% |
| Return on Capital Employed (ROCE) | -60.58% |
| Revenue Per Employee | $200 |
| Profits Per Employee | -$1.10M |
| Employee Count | 300 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.70% in the last 52 weeks. The beta is -0.08, so LYEL's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -1.70% |
| 50-Day Moving Average | 14.71 |
| 200-Day Moving Average | 11.57 |
| Relative Strength Index (RSI) | 53.51 |
| Average Volume (20 Days) | 27,741 |
Short Selling Information
The latest short interest is 183,877, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 183,877 |
| Short Previous Month | 233,067 |
| Short % of Shares Out | 0.96% |
| Short % of Float | 1.53% |
| Short Ratio (days to cover) | 2.91 |
Income Statement
In the last 12 months, LYEL had revenue of $60,000 and -$331.40 million in losses. Loss per share was -$23.52.
| Revenue | 60,000 |
| Gross Profit | 60,000 |
| Operating Income | -211.15M |
| Pretax Income | -331.40M |
| Net Income | -331.40M |
| EBITDA | -194.87M |
| EBIT | -211.15M |
| Loss Per Share | -$23.52 |
Full Income StatementBalance Sheet
The company has $276.79 million in cash and $55.11 million in debt, giving a net cash position of $241.74 million or $12.58 per share.
| Cash & Cash Equivalents | 276.79M |
| Total Debt | 55.11M |
| Net Cash | 241.74M |
| Net Cash Per Share | $12.58 |
| Equity (Book Value) | 298.92M |
| Book Value Per Share | 20.16 |
| Working Capital | 245.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$171.48 million and capital expenditures -$517,000, giving a free cash flow of -$172.00 million.
| Operating Cash Flow | -171.48M |
| Capital Expenditures | -517,000 |
| Free Cash Flow | -172.00M |
| FCF Per Share | -$8.95 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -351,916.67% |
| Pretax Margin | -552,328.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYEL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.19% |
| Shareholder Yield | -11.19% |
| Earnings Yield | -103.54% |
| FCF Yield | -53.74% |
Analyst Forecast
The average price target for LYEL is $16.67, which is 0.06% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.67 |
| Price Target Difference | 0.06% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 342.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
LYEL has an Altman Z-Score of -4.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.6 |
| Piotroski F-Score | 1 |
